Zoladex LA 10.8mg Depot Safesystem 10.8mg Syringe - Clinic Pack x3 POM
Add to wish list
Create new list
ℹ Important Notice: Pharma products are sold and shipped exclusively to registered medical professionals at verified medical premises.
Non-approved buyers:
Complete our Online POM Form, and we will notify you once your account is Pharma approved.
Zoladex 10.8 mg is indicated:
Zoladex Clinic Pack - Contains x3 J1383
- Metastatic prostate cancer:
Zoladex has demonstrated comparable survival benefits to surgical castrations.
- Locally advanced prostate cancer (alternative to surgical castration):
Zoladex has demonstrated comparable survival benefits to anti-androgen therapy.
- Adjuvant treatment to radiotherapy:
For patients with high-risk localised or locally advanced prostate cancer, Zoladex has demonstrated improved disease-free survival and overall survival.
- Neo-adjuvant treatment prior to radiotherapy:
In high-risk localised or locally advanced prostate cancer, Zoladex has demonstrated improved disease-free survival.
- Adjuvant treatment to radical prostatectomy:
For patients with locally advanced prostate cancer at high risk of disease progression, Zoladex has demonstrated improved disease-free survival (see section 5.1).
Nature and Contents of Container:
- Zoladex LA is supplied as a single dose SafeSystem™ syringe applicator with a protective sleeve in a sealed pouch containing a desiccant.
Special Precautions for Storage:
- Do not store above 25°C.
Patient Information Leaflet:
https://www.medicines.org.uk/emc/files/pil.1567.pdf